Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Motor Activity × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 88 Colorectal Neoplasms 53 Stomach Neoplasms 41 Rectal Neoplasms 34 Neoplasm Metastasis 19 Colonic Neoplasms 18 Nasopharyngeal Carcinoma 17 Triple Negative Breast Neoplasms 13 Neoplasms 12 Pancreatic Neoplasms 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Gallbladder Neoplasms 7 Cholangiocarcinoma 7 Esophageal Neoplasms 5 Adenocarcinoma Of Esophagus 5 Adenocarcinoma 5 Neuroendocrine Tumors 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Recurrence 2 Pathologic Complete Response 2 Liver Neoplasms 2 Intestinal Neoplasms 2 HER2-positive Advanced Breast Cancer 2 HER2 Positive Metastatic Breast Cancer 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2

Interventions

Exercise 8 tislelizumab 1 Vitamin D 1 Tea 1 Resistance Training 1 Probiotics 1 Oxaliplatin 1 Nutrition Assessment 1 Metformin 1 Leucovorin 1 Fluorouracil 1 Fish Oils 1 Diet Therapy 1 Diet 1 Curcumin 1 Counseling 1 Capecitabine 1 Caloric Restriction 1 Andrographis paniculata extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04488159 2024-09-20

iMAGINE

Medical University of Vienna

Phase 3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡